NA Sema 10mg
$50NA Semax 10mg offered by manufacturer Peptisource Co., Ltd.. Buy Semax 10mg directly with low price and high quality.
Showing 17–32 of 48 results

NA Semax 10mg offered by manufacturer Peptisource Co., Ltd.. Buy Semax 10mg directly with low price and high quality.

NA Semax 50mg offered by manufacturer Peptisource Co., Ltd.. Buy NA Semax 50mg directly with low price and high quality.

Nicotinamide adenine dinucleotide (NAD+), a key molecule widely present in living organisms, plays a vital role in maintaining health and extending lifespan. It serves a central role in cellular energy metabolism, supporting the normal functioning of cells, while also participating in DNA repair and cellular protection to help defend against oxidative stress and cellular damage. The advantages of NAD+ lie in its ability to activate anti-aging related factors, promote cell repair and regeneration, delay the aging process, enhance immunity, improve metabolic health, and exhibit positive effects in cardiovascular protection, neuroprotection, and other aspects. Its significance extends beyond maintaining daily health, as it also provides new possibilities for anti-aging and disease prevention.

PT 141 (Bremelanotide) is a synthetic cyclic heptapeptide drug that shows unique potential in the treatment of sexual dysfunction. Its development stems from the unremitting efforts of researchers to improve the quality of life of patients with sexual dysfunction. After years of research and experimentation, it has gradually come into the public view.

Retatrutide is a novel peptide drug. As a triple receptor agonist, it acts on the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously. It helps individuals lose weight by comprehensively regulating appetite, enhancing satiety, suppressing hunger, and increasing energy expenditure.

Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.

Retatrutide is a novel peptide-based drug belonging to the class of triple receptor agonists targeting GLP-1R/GIPR/GCGR, composed of 39 amino acids. Its design is inspired by endogenous intestinal insulin-like hormones (such as GIP) and, through structural optimization, it can simultaneously activate the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and glucagon receptor (GCGR). Activating GLP-1R promotes insulin secretion, inhibits glucagon release, lowers blood glucose levels, delays gastric emptying, and reduces appetite; activating GIPR enhances insulin secretion effects, further lowers blood glucose levels, and also plays a role in lipid metabolism; activating GCGR promotes energy expenditure, enhances hepatic gluconeogenesis inhibition, and reduces hepatic fat deposition.

Retatrutide is a novel peptide drug. As a triple receptor agonist, it acts on the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously. It helps individuals lose weight by comprehensively regulating appetite, enhancing satiety, suppressing hunger, and increasing energy expenditure.

Retatrutide is a peptide drug acting as a triple agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R), and glucagon receptor (GCGR), targeting conditions such as obesity and type 2 diabetes.

Selank, a synthetic peptide drug, is primarily used to improve anxiety, depression, and cognitive dysfunction. It exhibits anxiolytic and antidepressant effects, effectively alleviating anxiety and reducing depressive symptoms while significantly enhancing cognitive functions, including memory, attention, and learning abilities. Additionally, Selank has immunomodulatory effects, capable of enhancing the body's immune function. It is safe, well-tolerated, easy to use, and fast-acting. Selank is not only significant in the treatment of mental disorders, providing new options for conditions such as anxiety and depression, but also demonstrates potential value in neuroprotection and cognitive improvement, especially suitable for cases where conventional medications are ineffective or have side effects, helping to improve mental state and quality of life.

Semaglutide, as a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, is widely used in the clinical treatment of type 2 diabetes. The drug exerts multiple actions by mimicking the physiological effects of endogenous GLP-1: it promotes glucose-dependent insulin secretion, inhibits glucagon release, delays gastric emptying rate, and suppresses appetite, thereby achieving the dual objectives of glycemic regulation and weight management. Given its half-life of approximately seven days, a once-weekly subcutaneous administration regimen can be adopted in clinical practice; this pharmacokinetic property significantly improves patients’ treatment adherence.

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that extends the half-life of natural GLP-1 through structural modification. It mimics the physiological effects of GLP-1, promoting insulin secretion in a glucose-dependent manner, inhibiting glucagon release, delaying gastric emptying, and enhancing satiety. It effectively controls blood glucose levels in patients with type 2 diabetes, significantly reduces body weight in obese or overweight individuals, and lowers the risk of cardiovascular events. It is a peptide with dual benefits of blood glucose control, weight loss, and potential cardiovascular protection.


Sema, a peptide nootropic and synthetic analog of adrenocorticotropic hormone (ACTH), possesses cognitive-enhancing and neuroprotective properties. Its primary effects include improving attention, memory, and learning abilities, promoting neural repair, enhancing the body’s adaptability to damaging influences such as hypoxia and cerebral ischemia, and alleviating depressive and anxiety symptoms. Additionally, Sema has demonstrated significant efficacy in treating cerebrovascular diseases, Alzheimer's disease, cerebral infarction, and other conditions. Its advantages lie in the absence of toxic side effects, non-addictiveness, and notable neuroprotective and cognitive-enhancing effects in both healthy individuals and patients, while possessing multiple biological activities such as antioxidant, anti-inflammatory, and immunomodulatory effects.

SS-31 is a mitochondria-targeting peptide drug used to treat a variety of diseases associated with mitochondrial dysfunction by protecting mitochondrial membrane function and improving energy metabolism. It binds to cardiolipin in the inner mitochondrial membrane, stabilizes mitochondrial structure and function, reduces reactive oxygen species production and enhances ATP production, thereby improving mitochondrial function. It is well tolerated and in some cases has been shown to significantly improve patients' vision, with significant supportive therapeutic effects especially in Leber's hereditary optic neuropathy (LHON). It has therapeutic effects in a variety of mitochondrial dysfunction-related diseases such as heart failure and neurodegenerative diseases, relieving symptoms and slowing disease progression.

SS-31 is a small-molecule peptide composed of four amino acids. It contains partial D-type amino acids, exhibits strong resistance to protease degradation, and is also a cell-penetrating peptide. As a phospholipase A2 inhibitor and mitochondrial-targeted peptide, SS-31 specifically accumulates on the inner mitochondrial membrane and exerts its effects through multiple mechanisms.
No products in the cart.